肝纤维化诊断及其严重程度评估*

doi:10.3969/j.issn.1672-5069.2017.01.005

摘要/Abstract

Key words: Hepatic fibrosis, Diagnosis, Severity, Biopsy, Noninvasive measurement

胡烨, 张国. 肝纤维化诊断及其严重程度评估^*[J]. 实用肝脏病杂志, 2017, 20(1): 13-16.

Hu Ye, Zhang Guo.. Diagnosis, severity assessment of hepatic fibrosis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(1): 13-16.

[1] Goodman ZD. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol,2007,47（4）:598-607.
[2] Knodell RG,Ishak KG,Black WC,et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology,1981,1（5）:431-435.
[3] Brunt EM. Grading and staging the histopathological lesions of chronic hepatitis:the Knodell histology activity index and beyond. Hepatology,2000,31（1）:241-246.
[4] 王宝恩. 肝纤维化的诊断与严重度评估. 中华肝脏病杂志,1998,6（4）:193-194.
[5] Gaggini MC,Navarro RS,Stefanini AR,et al. Correlation between METAVIR scores and Raman spectroscopy in liver lesions induced by hepatitis C virus: a preliminary study. Lasers Med Sci,2015,30（4）:1347-1355.
[6] 郎振为. 病理学检测在慢性乙型肝炎诊断治疗中的价值. 世界华人消化杂志,2003,11（6）:772-774.
[7] 王松贤. 慢性乙型肝炎患者肝组织学检查的意义. 实用肝脏病杂志,2014,17（3）:297-298.
[8] 周红星. 慢性乙型肝炎临床和组织病理学诊断的对比研究. 中国医疗前沿,2013,8（23）:90-91.
[9] Chevallier M,Guerret S,Chossegros P,et al. A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens:comparison with morphometric studies. Hepatology,1994,20（2）:349-355.
[10] 王泰龄,刘霞,周元平,等. 慢性肝炎炎症活动度及纤维化程度计分方案. 中华肝脏病杂志,1998,6（4）:195-197.
[11] Kleiner DE,Brunt EM,Van Natta M,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology,2005,41（6）:1313-1321.
[12] Ludwig J,Barham SS,LaRusso NF,et al. Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology,1981,1（6）:632-640.
[13] Ludwig J,Dickson ER,McDonald GS. Staging of chronic nonsuppurative destructive cholangitis（syndrome of primary biliary cirrhosis）. Virchows Arch A Pathol Anat Histol,1978,379（2）:103-112.
[14] Banff schema for grading liver allograft rejection:an international consensus document. Hepatology,1997,25（3）:658-663.
[15] Xu S,Wang Y,Tai DC,et al. qFibrosis:a fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients. J Hepatol,2014,61（2）:260-269.
[16] 梁携儿,汪艳,侯金林. 肝纤维化定量诊断: 有创还是无创?临床肝胆病杂志,2015,31（3）:317-321.
[17] Asselah T,Marcellin P,Bedossa P. Improving performance of liver biopsy in fibrosis assessment. J Hepatol,2014,61（2）:193-195.
[18] Wang Y,Hou JL. Current strategies for quantitating fibrosis in liver biopsy. Chin Med J （Engl）,2015,128（2）:252-258.
[19] Almpanis Z,Demonakou M,Tiniakos D. Evaluation of liver fibrosis:“Something old,something new……”. Ann Gastroenterol,2016,29（4）:445-453.
[20] Vuppalanchi R,Sanyal AJ. Myths and mysteries about staging hepatic fibrosis by fibroscan. Clin Gastroenterol Hepatol,2015,13（4）:780-782.
[21] European Association for Study of L,Asociacion Latinoamericana para el Estudio del H. EASL-ALEH Clinical Practice Guidelines:Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol,2015,63（1）:237-264.
[22] 瞬时弹性成像技术（TE）临床应用共识专家委员会. 瞬时弹性成像技术（TE）临床应用专家共识（2015年）. 中国肝脏病杂志（电子版）,2015,7（2）:12-18.
[23] Corpechot C,Gaouar F,El Naggar A,et al. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis. Gastroenterology,2014,146（4）: 970-979; quiz e915-976.
[24] 刘倚河,廖瑞真,秦青秀,等. 声辐射力脉冲成像技术对肝纤维化分级的应用价值. 临床军医杂志,2013,41（3）:300-303.
[25] 邓锡源,马苏美,李辉,等. ARFI技术与血清总胆汁酸在慢性丙型肝炎肝硬化Child-Pugh分级中的应用. 世界华人消化杂志,2016,24（2）:287-292.
[26] Su LN,Guo SL,Li BX,et al. Diagnostic value of magnetic resonance elastography for detecting and staging of hepatic fibrosis:a meta-analysis. Clin Radiol,2014,69（12）:e545-552.
[27] 杨明磊,姚定康. 磁共振弹性成像在肝纤维化无创诊断中的应用. 临床肝胆病杂志,2016,32（3）:588-592.
[28] Singh S,Venkatesh SK,Wang Z,et al. Diagnostic performance of magnetic resonance elastography in staging liver fibrosis:a systematic review and meta-analysis of individual participant data. Clin Gastroenterol Hepatol,2015,13（3）:440-451 e446.
[29] Singh S,Venkatesh SK,Loomba R,et al. Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease:a diagnostic accuracy systematic review and individual participant data pooled analysis. Eur Radiol,2016,26（5）: 1431-1440.
[30] Li B,Min J,Liang WR,et al. Use of magnetic resonance elastography for assessing liver functional reserve:A clinical study. World J Gastroenterol,2015,21（24）:7522-7528.
[31] Zeng DW,Dong J,Liu YR,et al. Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection. World J Gastroenterol,2016,22（29）:6663-6672.
[32] Myers RP,Tainturier MH,Ratziu V,et al. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J Hepatol,2003,39（2）:222-230.
[33] Hui AY,Chan HL,Wong VW,et al. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am J Gastroenterol,2005,100（3）: 616-623.
[34] Zeng MD,Lu LG,Mao YM,et al. Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model. Hepatology,2005,42（6）:1437-1445.
[35] Zhou K,Gao CF,Zhao YP,et al. Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B. J Gastroenterol Hepatol,2010,25（9）:1569-1577.
[36] Siddiqui MS,Patidar KR,Boyett S,et al. Performance of non-invasive models of fibrosis in predicting mild to moderate fibrosis in patients with non-alcoholic fatty liver disease. Liver Int,2016,36（4）:572-579.
[37] Wong GL,Chan HL,Yu Z,et al. Noninvasive assessments of liver fibrosis with transient elastography and Hui index predict survival in patients with chronic hepatitis B. J Gastroenterol Hepatol,2015,30（3）:582-590.
[38] Wong GL,Wong VW,Choi PC,et al. Development of a non-invasive algorithm with transient elastography（Fibroscan） and serum test formula for advanced liver fibrosis in chronic hepatitis B. Aliment Pharmacol Ther,2010,31（10）:1095-1103.
[39] Liao R,Fu YP,Wang T,et al. Metavir and FIB-4 scores are associated with patient prognosis after curative hepatectomy in hepatitis B virus-related hepatocellular carcinoma:a retrospective cohort study at two centers in China. Oncotarget,2016（ahead of print）.
[40] Boursier J,de Ledinghen V,Zarski JP,et al. Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C:new algorithms are more precise and entirely noninvasive. Hepatology,2012,55（1）:58-67.
[41] Castera L,Sebastiani G,Le Bail B,et al. Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C. J Hepatol,2010,52（2）:191-198.
[42] Boursier J,de Ledinghen V,Zarski JP,et al. A new combination of blood test and fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C. Am J Gastroenterol,2011,106（7）:1255-1263.
[43] Attallah AM,El-Far M,Abdel Malak CA,et al. Fibro-check:a combination of direct and indirect markers for liver fibrosis staging in chronic hepatitis C patients. Ann Hepatol,2015,14（2）:225-233.
[44] Liu Y,Dong CF,Yang G,et al. Optimal linear combination of ARFI,transient elastography and APRI for the assessment of fibrosis in chronic hepatitis B. Liver Int,2015,35（3）:816-825.

肝纤维化诊断及其严重程度评估^*

Diagnosis, severity assessment of hepatic fibrosis

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	中国研究型医院学会肝病专业委员会, 中国医师协会脂肪性肝病专家委员会. 脂肪性肝病诊疗规范化的专家建议（2019年修订版）[J]. 实用肝脏病杂志, 2019, 22(6): 787-792.
[2]	. 肝纤维化诊断及治疗共识（2019年）[J]. 实用肝脏病杂志, 2019, 22(6): 793-803.
[3]	闵峰, 黄文琪, 吴卫兵, 张丽, 范荣华. 慢性乙型肝炎患者血清脂肪细胞因子水平变化及其临床意义^*[J]. 实用肝脏病杂志, 2019, 22(6): 824-827.
[4]	吴海义, 陈建新. 四种诊断模型诊断乙型肝炎病毒携带者肝纤维化的效能分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 832-835.
[5]	陈梅梅, 段晓燕, 曹海霞, 丁雯瑾. 复方鳖甲软肝片治疗原发性胆汁性肝硬化患者疗效分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 880-883.
[6]	曹策, 郁义星, 王贝贝, 赵卫峰. 增强磁共振成像联合血清甲胎蛋白和脱-γ-羧基凝血酶原诊断肝细胞癌临床价值探讨[J]. 实用肝脏病杂志, 2019, 22(6): 896-899.
[7]	曾艳妮, 张灿, 毕俊英, 刘良进, 孟俊, 秦涛. MRI长时间延迟增强扫描诊断肝脏孤立性坏死性结节价值研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 900-903.
[8]	邢昊, 韩骏, 杨田. 应用血清PIVKA-II诊断肝细胞癌研究进展^*[J]. 实用肝脏病杂志, 2019, 22(6): 934-937.
[9]	梁巨波, 苗琪, 马雄. 胆管细胞型胆汁淤积诊治进展[J]. 实用肝脏病杂志, 2019, 22(6): 941-943.
[10]	高伟, 侯勇. 肝脏硬度值检测诊断慢性乙型肝炎患者肝组织纤维化的效能分析*[J]. 实用肝脏病杂志, 2019, 22(5): 652-655.
[11]	黄汉军, 鲁凤荣, 张灿. 基于Exchange血流动力学模型的MRI扫描参数诊断肝硬化临床价值分析*[J]. 实用肝脏病杂志, 2019, 22(5): 696-699.
[12]	洪佳, 吴晓宁, 尤红. 胆汁淤积性肝病的规范化诊断[J]. 实用肝脏病杂志, 2019, 22(5): 758-760.
[13]	程华, 鞠辉, 宋德顺, 李伟. 慢性乙型肝炎患者血清血管生成素样蛋白2和高尔基体蛋白73水平变化及其诊断显著肝纤维化的效能分析^*[J]. 实用肝脏病杂志, 2019, 22(4): 494-497.
[14]	余英芳, 温生宝. 应用磁共振DWI单指数、双指数和拉伸指数模型参数评估慢性乙型肝炎患者肝纤维化程度效能研究^*[J]. 实用肝脏病杂志, 2019, 22(4): 502-505.
[15]	张亚飞, 叶珺, 谢琴秀, 邹桂舟, 李家斌, 李旭, 张振华. 不同医院无创性肝纤维化指标预测慢性乙型肝炎患者肝纤维化效能差异分析^*[J]. 实用肝脏病杂志, 2019, 22(4): 510-513.